Abstract

To date, the association of an imbalance of the intestinal microbiota with various human diseases, including both diseases of the gastrointestinal tract and disorders of the immune system, has been shown. However, despite the huge amount of accumulated data, many key questions still remain unanswered. Given limited data on the composition of the gut microbiota in patients with ulcerative colitis (UC) and irritable bowel syndrome (IBS) from different parts of Siberia, as well as the lack of data on the gut microbiota of patients with bronchial asthma (BA), the aim of the study was to assess the biodiversity of the gut microbiota of patients with IBS, UC and BA in comparison with those of healthy volunteers (HV). In this study, a comparative assessment of the biodiversity and taxonomic structure of gut microbiome was conducted based on the sequencing of 16S rRNA genes obtained from fecal samples of patients with IBS, UC, BA and volunteers. Sequences of the Firmicutes and Bacteroidetes types dominated in all samples studied. The third most common in all samples were sequences of the Proteobacteria type, which contains pathogenic and opportunistic bacteria. Sequences of the Actinobacteria type were, on average, the fourth most common. The results showed the presence of dysbiosis in the samples from patients compared to the sample from HVs. The ratio of Firmicutes/Bacteroidetes was lower in the IBS and UC samples than in HV and higher the BA samples. In the samples from patients with intestinal diseases (IBS and UC), an increase in the proportion of sequences of the Bacteroidetes type and a decrease in the proportion of sequences of the Clostridia class, as well as the Ruminococcaceae, but not Erysipelotrichaceae family, were found. The IBS, UC, and BA samples had signif icantly more Proteobacteria sequences, including Methylobacterium, Sphingomonas, Parasutterella, Halomonas, Vibrio, as well as Escherichia spp. and Shigella spp. In the gut microbiota of adults with BA, a decrease in the proportion of Roseburia, Lachnospira, Veillonella sequences was detected, but the share of Faecalibacterium and Lactobacillus sequences was the same as in healthy individuals. A signif icant increase in the proportion of Halomonas and Vibrio sequences in the gut microbiota in patients with BA has been described for the f irst time.

Highlights

  • Введение К настоящему времени накоплено достаточно данных о микробных сообществах кишечника человека и показана ассоциация дисбаланса кишечной микробиоты с различными патологическими состояниями, в том числе не только заболеваниями желудочно-кишечного тракта, но и нарушениями иммунной системы (O’Hara, Shanahan, 2006)

  • The results showed the presence of dysbiosis in the samples from patients compared to the sample from healthy volunteers (HV)

  • Samples 1–8 were obtained from patients with irritable bowel syndrome (IBS); 9–26 from patients with ulcerative colitis (UC); 27–34 from patients with bronchial asthma; and 35–42 from healthy volunteers (HV)

Read more

Summary

Результаты и обсуждение

Оценка биоразнообразия бактериальных сообществ На основе ДНК, выделенной из образцов фекалий пациентов и доноров, сконструированы 42 библиотеки фрагментов гена 16S рРНК. Фрагменты содержали вариа­ бельные участки V3 и V4 гена 16S рРНК – на основе этой последовательности возможна таксономическая классификация большинства бактерий (Chakravorty et al, 2007; Wang, Qian, 2009). Средний возраст добровольцев в группе ЗД был достоверно ниже в сравнении с группами пациентов с БА, СРК и ЯК ( p ≤ 0.01 во всех случаях); при этом данный показатель в трех выборках больных статистически значимо не различался. Оценка выборок методом главных компонентов показала, что наиболее компактно расположены точки, характеризующие библиотеки последовательностей из группы ЗД Расположение точек, характеризую­ щих библиотеки из выборок пациентов, при меньшем значении индекса Шеннона по сравнению с таковым для ЗД свидетельствует об относительной нестабильности микробиомов у таких больных

The overall number of bacterium classes
Betaproteobacteriales Sphingomonadales Bifidobacteriales
IBS UC Asthma HV
Findings
ORCID ID

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.